Join us in-person in Munich, Germany for the ESCMID Global 2026 event. Learn more about our involvement in the event below.
Evotec at ESCMID Global 2026
Presentation
First-in-Human Study of EVT894, a Monoclonal Antibody Against Chikungunya Virus
Date and Time: Saturday 18th April, 8:30 AM
Presenter: Hugh Watson, Consultant Molecular Glue Discovery & Development
